Kala Bio Initiates 1-for-50 Reverse Split, Reduces Shares Outstanding to 18.6M
KALA BIO will execute a 1-for-50 reverse stock split effective May 8, 2026, with split-adjusted trading beginning May 11 on the Nasdaq Capital Market. The split reduces outstanding shares from 929,491,578 to about 18,589,832, with fractional shareholders receiving cash based on the May 7 closing price.
1. Split Terms and Timing
KALA BIO will effect a 1-for-50 reverse stock split at 4:05 p.m. ET on May 8, 2026. Shares will trade on a split-adjusted basis under the existing symbol when markets open May 11 on the Nasdaq Capital Market.
2. Impact on Shares Outstanding
The reverse split will reduce the number of issued and outstanding common shares from 929,491,578 to approximately 18,589,832 without changing any stockholder’s percentage equity interest. Proportional adjustments will apply to all outstanding equity awards, warrants and convertible securities.
3. Fractional Shares and Shareholder Actions
No fractional shares will be issued; holders of fractional interests will receive a cash payment based on the closing price on May 7, 2026. Brokerage account holdings will adjust automatically, while certificated shareholders may exchange certificates if they choose.